CN114144418A - 喹唑啉类化合物的晶型、盐型及其制备方法 - Google Patents
喹唑啉类化合物的晶型、盐型及其制备方法 Download PDFInfo
- Publication number
- CN114144418A CN114144418A CN202080044785.6A CN202080044785A CN114144418A CN 114144418 A CN114144418 A CN 114144418A CN 202080044785 A CN202080044785 A CN 202080044785A CN 114144418 A CN114144418 A CN 114144418A
- Authority
- CN
- China
- Prior art keywords
- degrees
- compound
- formula
- angles
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (34)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910533240 | 2019-06-19 | ||
CN201910533240.0 | 2019-06-19 | ||
PCT/CN2020/097158 WO2020253836A1 (zh) | 2019-06-19 | 2020-06-19 | 喹唑啉类化合物的晶型、盐型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114144418A true CN114144418A (zh) | 2022-03-04 |
CN114144418B CN114144418B (zh) | 2023-10-10 |
Family
ID=74040641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080044785.6A Active CN114144418B (zh) | 2019-06-19 | 2020-06-19 | 喹唑啉类化合物的晶型、盐型及其制备方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220242851A1 (zh) |
EP (1) | EP3988553A4 (zh) |
JP (1) | JP7350374B2 (zh) |
CN (1) | CN114144418B (zh) |
WO (1) | WO2020253836A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117567466A (zh) * | 2024-01-16 | 2024-02-20 | 成都金瑞基业生物科技有限公司 | 一种喹唑啉衍生物的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101679384A (zh) * | 2007-06-05 | 2010-03-24 | 韩美药品株式会社 | 用于抑制癌细胞生长的新酰胺衍生物 |
CN105461729A (zh) * | 2015-11-18 | 2016-04-06 | 乳源瑶族自治县大众药品贸易有限公司 | 一种egfr抑制剂的盐、晶型及其用途 |
CN105555782A (zh) * | 2013-09-28 | 2016-05-04 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物及其制备方法 |
WO2019120213A1 (zh) * | 2017-12-19 | 2019-06-27 | 南京明德新药研发股份有限公司 | 喹唑啉衍生物及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107406430B (zh) | 2015-03-20 | 2019-04-26 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物的盐及其制备方法 |
WO2017067447A1 (en) | 2015-10-19 | 2017-04-27 | Sunshine Lake Pharma Co., Ltd. | A salt of egfr inhibitor, crystalline form and uses thereof |
CN105294717B (zh) * | 2015-11-18 | 2017-12-22 | 乳源瑶族自治县大众药品贸易有限公司 | 一种egfr抑制剂的盐、晶型及其用途 |
-
2020
- 2020-06-19 JP JP2021575887A patent/JP7350374B2/ja active Active
- 2020-06-19 WO PCT/CN2020/097158 patent/WO2020253836A1/zh unknown
- 2020-06-19 US US17/620,464 patent/US20220242851A1/en active Pending
- 2020-06-19 EP EP20827468.8A patent/EP3988553A4/en active Pending
- 2020-06-19 CN CN202080044785.6A patent/CN114144418B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101679384A (zh) * | 2007-06-05 | 2010-03-24 | 韩美药品株式会社 | 用于抑制癌细胞生长的新酰胺衍生物 |
CN105555782A (zh) * | 2013-09-28 | 2016-05-04 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物及其制备方法 |
CN105461729A (zh) * | 2015-11-18 | 2016-04-06 | 乳源瑶族自治县大众药品贸易有限公司 | 一种egfr抑制剂的盐、晶型及其用途 |
WO2019120213A1 (zh) * | 2017-12-19 | 2019-06-27 | 南京明德新药研发股份有限公司 | 喹唑啉衍生物及其应用 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117567466A (zh) * | 2024-01-16 | 2024-02-20 | 成都金瑞基业生物科技有限公司 | 一种喹唑啉衍生物的制备方法 |
CN117567466B (zh) * | 2024-01-16 | 2024-04-16 | 成都金瑞基业生物科技有限公司 | 一种喹唑啉衍生物的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP3988553A1 (en) | 2022-04-27 |
EP3988553A4 (en) | 2023-06-14 |
US20220242851A1 (en) | 2022-08-04 |
JP2022537758A (ja) | 2022-08-29 |
JP7350374B2 (ja) | 2023-09-26 |
WO2020253836A1 (zh) | 2020-12-24 |
CN114144418B (zh) | 2023-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3867251B1 (en) | Kras g12c inhibitors | |
AU2018212647B2 (en) | Combination therapy involving diaryl macrocyclic compounds | |
CN107108648B (zh) | 作为ERK抑制剂的噻吩并[2,3-c]吡咯-4-酮衍生物 | |
CN106928150B (zh) | 丙烯酰胺苯胺衍生物及其药学上的应用 | |
EP2491032B1 (en) | Akt inhibitors | |
JP7312335B2 (ja) | Braf関連疾患および障害を処置するための4-オキソ-3,4-ジヒドロキナゾリノン化合物 | |
EP3102571B1 (en) | Substituted pyrimidines useful as egfr-t790m kinase inhibitors | |
Fan et al. | Discovery of Dioxino [2, 3-f] quinazoline derivative VEGFR-2 inhibitors exerting significant antipro-liferative activity in HUVECs and mice | |
KR20210150476A (ko) | 헤테로시클릭 화합물 및 그의 용도 | |
CN110857292A (zh) | 一种egfr激酶抑制剂及其制备方法和应用 | |
CN114728957A (zh) | 一种atr抑制剂的晶型及其应用 | |
CN114144418A (zh) | 喹唑啉类化合物的晶型、盐型及其制备方法 | |
CN112351971B (zh) | 喹啉或喹唑啉类化合物及其应用 | |
JP2019513730A (ja) | 癌を治療するためのATM(毛細血管拡張性運動失調症変異)キナーゼモジュレータとしてのN,N−ジメチル−3−[[5−(3−メチル−2−オキソ−1−テトラヒドロピラン−4−イル−イミダゾ[4,5−c]キノリン−8−イル)−2−ピリジル]オキシ]プロパン−1−アミンオキシド | |
CN115448874A (zh) | 固体形式的周期蛋白依赖性激酶9抑制剂及其用途 | |
EP3971175A1 (en) | Crystal form of quinazolinone compound and preparation method therefor | |
WO2021088987A1 (zh) | 作为选择性her2抑制剂的盐型、晶型及其应用 | |
CN116018343A (zh) | 一种吡啶并嘧啶化合物的晶型 | |
Wang et al. | Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis | |
CN116003406B (zh) | 杂芳环氮氧化合物及其制备方法和应用 | |
EP2896622B1 (en) | Pi3k and/or mtor inhibitor | |
Cui et al. | Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2 | |
WO2020224585A1 (zh) | 一种mTORC1/2双激酶活性抑制剂的盐型、晶型及其制备方法 | |
CN117327101A (zh) | 取代的杂环化合物 | |
CN103772411A (zh) | 含硫6-呋喃基喹唑啉-4-胺化合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40065055 Country of ref document: HK |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221205 Address after: No. 2004, 20th Floor, Building 1, No. 333, North Yizhou Avenue, Chengdu Hi tech Zone, China (Sichuan) Pilot Free Trade Zone, 610000, Sichuan Applicant after: Chengdu Jinrui Jiye Bio-Technology Co.,Ltd. Address before: 518118 innovation Plaza a2402, No. 2007, Pingshan Avenue, Liulian community, Pingshan street, Pingshan District, Shenzhen, Guangdong Applicant before: Shenzhen jinruijiye Biotechnology Co.,Ltd. Applicant before: Nanjing Mingde New Drug Development Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |